Можливості хірургічного лікування цукрового діабету 2-го типу

В. В. Грубнік, В. П. Голляк, М. С. Кресюн, К. О. Воротинцева

Анотація


Type 2 diabetes mellitus (T2DM) is a global problem of world healthcare. In 2000, the disease struck about 171 million people around the world, the growth rate of this disease is very high, and by 2030 the number of patients with this condition will reach 366 million people. This is a heterogeneous disorder caused by deficiency of both insulin secretion and resistance of insulin. It is believed that one of the risk factors for type 2 diabetes is obesity – in 80-90% of patients with type 2 diabetes obesity occurs. Initially bariatric surgery is considered an effective method of weight loss in individuals with a BMI>40 kg/m2. However, it appeared that when the bariatric operations remission diabetes is fast enough even with a significant reduction of body weight. At present there are different types of surgery in the treatment of obese patients with type 2 diabetes. These include the operation of the decline in the stomach, malabsortive operation under which the intestinal bypass, and mixed types of transactions in which restrictive and malabsortive technology are combined. Type 2 diabetes is considered to be a disease of the pancreas. Combined bariatric surgery can significantly improve the treatment of this disease by affecting the intestinal factor of this disease.

Ключові слова


bariatric surgery; gastric bypass surgery; diabetes; obesity

Повний текст:

PDF

Посилання


American Diabetes Association. Standards of medical care in diabetes – 2009 // Diabetes Care. – 2009. – Vol. 32. – P. 13-61. https://doi.org/10.2337/dc09-s013

Bikman B.T., Zheng D., Porics W.J. et al. Mechanisms for improved insulin sensitivity after gastric bypass surgery // J. Clin. Endocrinol. Metab. – 2008. – Vol. 93. – P. 4656-4563. https://doi.org/10.1210/jc.2008-1030

Bottino R., Trucco M. Multifeceted therapeutic approaches for a multigenic disease // Diabetes. – 2005. – Vol. 54. – P. 79-86. https://doi.org/10.2337/diabetes.54.suppl_2.s79

Briatore L., Salani B., Andraghetti G. et al. Restoration of acute insulin response in T2DM subjects 1 month after biliopancreatic diversion // Obesity. – 2008. – Vol. 16. – P. 77-81. https://doi.org/10.1038/oby.2007.9

Buchwald H., Avidor Y., Braunwald E. et al. Bariatric surgery: a systematic review and meta-analysis // JAMA. – 2004. – Vol. 292. – P. 1724-1737. https://doi.org/10.1001/jama.292.14.1724

Canadian Diabetes Association. Clinical practice guidelines for the prevention and management of diabetes in Canada. – Toronto: Canadian Diabetes Association, 2008. – P. 77.

Dixon J.B. Obesity and diabetes: the impact of bariatric surgery on type-2 diabetes // World J. Surg. – 2009. – Vol. 33. – P. 2014-2021. https://doi.org/10.1007/s00268-009-0062-y

Guidone C., Manco M., Valera-Mora E. et al. Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery // Diabetes. – 2006. – Vol. 55. – P. 2025-2031. https://doi.org/10.2337/db06-0068

Hall T.C., Pellen M.G., Sedman P.C. et al. Preoperative factors predicting remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery for obesity // Obes. Surg. – 2010. – Vol. 20. – P. 1245-1250. https://doi.org/10.1007/s11695-010-0198-8

Hoist J.J. Pcdersen J.I.I., Baldissera F. et al. Circulating glucagon after total pancreatectomy in man // Diabetology. – 1983. – Vol. 25. – P. 396-399. https://doi.org/10.1007/bf00282517

Kashyap S.R., Daud S., Kelly K.R. et al. Acute effect of gastric bypass versus gastric restrictive surgery on B-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes // Int. J. Obes. (Lond). – 2010. – Vol. 34. – P. 462-471. https://doi.org/10.1038/ijo.2009.254

Masharami U., Karam J.H. et al. Hormonios pancreaticus e diabetes melito. In: Greenspan F.S., Gardner D.G., editors. Endocrinologia Basica e Clinica. – New York: McGraw-Hill, 2006. – P. 541-555.

Mingrone G., Castagneto-Gissey L. Mechanisms of early improvement/resolution of type 2 diabetes after bariatric surgery // Diabetes Metab. – 2009. – Vol. 35. – P. 518-523. https://doi.org/10.1016/s1262-3636(09)73459-7

Mithieux O. The new functions of the gut in the control of glucose homeostasis // Curr. Opin. Clin. Nutr. Metab. Care. – 2005. – Vol. 8. – P. 445-449. https://doi.org/10.1097/01.mco.0000172587.17385.aa

Parikh M., Duncombe J., Fielding G.A. Laparoscopic adjustable gastric banding for patients with body mass index of ≤35 kg/m2 // Surg. Obes. Relat. Dis. – 2006. – Vol. 2. – P. 518-522. https://doi.org/10.1016/j.soard.2006.07.005

Patriti A., Facchiano E., Annetti C. et al. Early improvement of glucose tolerance after ileal transposition in a non-obese type 2 diabetes rat model // Obes. Surg. – 2005. – Vol. 15. – P. 1258-1264. https://doi.org/10.1381/096089205774512573

Pories W.J., Swanson M.S., McDonald I.C.G. et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus // Annals of Surg. – 1995. – Vol. 222. – P. 339-350. https://doi.org/10.1097/00000658-199509000-00011

Pories W.J. Bariatric surgery: risks and rewards / / J. Clin. Endocrinol. Metab. – 2008. – Vol. 93. – P. 89-96. https://doi.org/10.1210/jc.2008-1641

Rodrigucz-Grunert L., Galvao Neto M.P., Alamo M. et al. First human experience with endoscopically delivered and retrieved duodcnal-jejunal bypass sleeve // Surg. Obes. Relat. Dis. – 2008. – Vol. 4. – P. 55-59. https://doi.org/10.1016/j.soard.2007.07.012

Rubino F., Marescaux J. Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease // Annals of Surg. – 2004. – Vol. 239. – P. 1-11. https://doi.org/10.1097/01.sla.0000102989.54824.fc

Rubino F., Schauer P.R., Kaplan L.M. et al. Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action // Ann. Rev. Med. – 2010. – Vol. 61. – P. 393-411. https://doi.org/10.1146/annurev.med.051308.105148

Sartorelli D.S., Franco L.J. Trends in diabetes mellitus in Brazil: the role of the nutritional transition // Cad Saude Publica. – 2003. – Vol. 19. – P. 29-36. https://doi.org/10.1590/s0102-311x2003000700004

Schauer P.R., Burguera B., Ikramuddin S. et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus // Annals of Surg. – 2003. – Vol. 238. – P. 467-484. https://doi.org/10.1097/01.sla.0000089851.41115.1b

Scheen A.J., De Flines J., De Roover A. et al. Bariatric surgery in patients with type 2 diabetes: benefits, risks, indications and perspectives // Diabetes Metab. – 2009. – Vol. 35. – P. 537-543. https://doi.org/10.1016/s1262-3636(09)73463-9

Scopinaro N., Marinari G.M., Camerini G.B. et al. Specific effects of biliopancreatic diversion on the major components of metabolic syndrome: a longterm follow-up study // Diabetes Care. – 2005. – Vol. 28. – P. 2406-2411. https://doi.org/10.2337/diacare.28.10.2406

Shafrir E. Development and consequences of insulin resistance: lessons from animals with hyperinsulinaemia // Diabetes Metab. – 1996. – Vol. 22. – P. 122-131.

Shulman G.I. Cellular mechanisms of insulin resistance // J. Clin. Invest. – 2000. – Vol. 106. – P. 171-176. https://doi.org/10.1172/jci10583

Strader A.D., Vahl T.P., Jandacck R.J. et al. Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats // Am. J. Physiol. Endocrinol. Metab. – 2005. – Vol. 288. – P. E447-E453. https://doi.org/10.1152/ajpendo.00153.2004

Thim L., Moody A.J. The primary structure of porcine glicentin (proglucagon) // Regul. Pept. – 1981. – Vol. 2. – P. 139-150. https://doi.org/10.1016/0167-0115(81)90007-0

Vilsboll T. On the role of the incretin hormones GIP and GLP-1 in the pathogenesis of type 2 diabetes mellitus // Dan. Med. Bull. – 2004. – Vol. 51. – P. 364-370.

Wickremesekera K., Miller G., Naotunne T.D. et ai. Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study // Obes. Surg. – 2005. – Vol. 15. – P. 474-481. https://doi.org/10.1381/0960892053723402

Wild S., Roglic G., Green A. et al. Global prevalence of diabetes. Estimates for the year 2000 and projections for 2030 // Diabetes Care. – 2004. – Vol. 27. – P. 1047-1053. https://doi.org/10.2337/diacare.27.5.1047

Wilson J.B., Pories W.J. Durable remission of diabetes after bariatric surgery: what is the underlying pathway? // Insulin. – 2010. – Vol. 5. – P. 46-55. https://doi.org/10.1016/s1557-0843(10)80009-0

World Health Organization. Facts sheet on diabetes, obesity and overweight. Geneva: World Health Organization; 2006.


Пристатейна бібліографія ГОСТ






DOI: https://doi.org/10.24026/1818-1384.2(43).2013.91949



Creative Commons License
Ця робота ліцензована Creative Commons Attribution-NonCommercial 4.0 International License.

© Клінічна ендокринологія та ендокринна хірургія.

ISSN: 1818-1384 (Print), e-ISSN: 2519-2582, DOI: 10.24026/1818-1384.

При копіюванні активне посилання на матеріал обов'язкове.

Flag Counter